Literature DB >> 11097786

Cancer and male infertility.

A Giwercman1, P M Petersen.   

Abstract

An increasing proportion of boys and young men with cancer will survive their disease and desire fertility. Unfortunately, the cancer treatment, and in some cases the malignant disease itself, may have a negative and permanent impact on the individual's fertility potential. This effect is highly dependent on the type and dose of therapy as well as the age at which it has been given. Basic knowledge in this field is necessary to enable oncologists and fertility specialists to counsel these patients about their fertility prospects and, if appropriate, advise them to take precautions (e.g. the cryopreservation of semen) to safeguard their fertility. Another aspect of the relationship between cancer and infertility is the possibility that men with testicular dysfunction may have an increased risk of testicular cancer. Screening for early testicular malignancy may therefore be advisable in some groups of men with poor semen quality. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097786     DOI: 10.1053/beem.2000.0091

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Endocrinol Metab


  13 in total

1.  Oncofertility in Canada: the impact of cancer on fertility.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

Review 2.  Fertility considerations in men with testicular cancer.

Authors:  Neel V Parekh; Scott D Lundy; Sarah C Vij
Journal:  Transl Androl Urol       Date:  2020-01

Review 3.  Fertility preservation in men with cancer.

Authors:  Koji Chiba; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2014-04-26

4.  Sperm banking and the cancer patient.

Authors:  Daniel H Williams
Journal:  Ther Adv Urol       Date:  2010-02

5.  Preservation of sperm of cancer patients: extent of use and pregnancy outcome in a tertiary infertility center.

Authors:  Amnon Botchan; Shiri Karpol; Ofer Lehavi; Gedalia Paz; Sandra E Kleiman; Leah Yogev; Haim Yavetz; Ron Hauser
Journal:  Asian J Androl       Date:  2013-03-25       Impact factor: 3.285

6.  Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.

Authors:  L Foppiani; M Baffico; G Lando; C Cappi; P De Cassan; M C Patrosso; A Vitali; S Penco; M Giusti; F Minuto
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

7.  Erectile dysfunction in successfully treated lymphoma patients.

Authors:  Sercan Aksoy; Hakan Harputluoglu; Saadettin Kilickap; Murat Dincer; Omer Dizdar; Bulent Akdogan; Haluk Ozen; Mustafa Erman; Ismail Celik
Journal:  Support Care Cancer       Date:  2007-07-28       Impact factor: 3.603

Review 8.  Fertility preservation in the male with cancer.

Authors:  Daniel H Williams
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

9.  Sperm chromatin integrity: etiologies and mechanisms of abnormality, assays, clinical importance, preventing and repairing damage.

Authors:  Azita Hekmatdoost; Niknam Lakpour; Mohammad Reza Sadeghi
Journal:  Avicenna J Med Biotechnol       Date:  2009-10

10.  Candesartan Mediated Amelioration of Cisplatin-Induced Testicular Damage Is Associated with Alterations in Expression Patterns of Nephrin and Podocin.

Authors:  Noritoshi Enatsu; Hideaki Miyake; Koji Chiba; Masato Fujisawa
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.